Fundraising FoxFlagship Ventures — 2013 Investments
1 investments dated 2013 · listed companies and verified rows first · show all
Syros Pharmaceuticals, Inc.syros.comApr 2013
Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.
Cambridge, US
Nancy Simonian(CEO)
Co-investorsAisling CapitalARCH Venture PartnersQuan CapitalAlexandriaAlly Bridge GroupBain Capital+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.